CCCC NASDAQ
C4 Therapeutics, Inc.
1W: -1.0%
1M: -22.2%
3M: -28.7%
YTD: +52.9%
1Y: +37.2%
3Y: +63.0%
5Y: -94.0%
$2.95
-0.19 (-6.05%)
Weekly Expected Move ±7.7%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$35M
Revenue
+2.3% YoY
$-101M
Net Income
+9.1% YoY
$-85M
Free Cash Flow
+2.5% YoY
100.0%
Gross Margin
-397.9%
Op. Margin
-355.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-48.1%
ROA-30.9%
ROIC-175.0%
Valuation
P/E-3.0
P/B1.6
EV/EBITDA-4.2
Leverage
Debt/Equity0.23
Current Ratio5.45
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z0.08
Beneish M-1.86